Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
42 studies found for:    DESOGESTREL AND ETHINYL ESTRADIOL
Show Display Options
Rank Status Study
1 Completed
Has Results
An Efficacy and Safety Study Comparing Oral Contraceptive Containing Norgestimate or Desogestrel for Acne Treatment
Condition: Acne Vulgaris
Interventions: Drug: Ethinyl estradiol/Norgestimate (EE/NGM);   Drug: Ethinyl estradiol/Desogestrel (EE/DSG)
2 Completed Comparative Trial in Hormone Withdrawal Associated Symptoms
Condition: Oral Contraceptive
Interventions: Drug: EE20/DRSP (YAZ, BAY86-5300);   Drug: Ethinylestradiol (EE) and desogestrel (DSG) (Mercilon)
3 Unknown  Evaluation of an Oral Contraceptive Containing 30 mg Ethinyloestradiol and 150 mg Desogestrel on Women's Health
Condition: Women With PMS
Intervention: Drug: Marvelon
4 Completed
Has Results
Hormonal Contraception and Vaginal Health
Conditions: Contraceptive Usage;   Vaginal Epithelial Disruption
Interventions: Drug: Desogen (ethinyl estradiol and desogestrel);   Drug: NuvaRing (ethinyl estradiol and etonogestrel)
5 Completed
Has Results
A Study to Evaluate Hormone Patterns and Ovarian Follicular Activity With DR-1021
Condition: Healthy
Interventions: Drug: DR-1021;   Drug: Mircette®;   Drug: Kariva®
6 Completed Premenstrual Symptoms Treatment Comparing Between Oral Contraceptives Containing Desogestrel and Drospirenone
Condition: Premenstrual Syndrome
Interventions: Drug: EE 20 microgram with desogestrel 150 mg;   Drug: EE 20 microgram with drospirenone 3 mg
7 Completed A Clinical Study on Yasmin® vs. Marvelon® in Chinese Women Requiring Contraception
Condition: Contraception
Interventions: Drug: Yasmin;   Drug: Marvelon
8 Completed
Has Results
A Multinational Study to Evaluate the Effects of a 28-Day Oral Contraceptive on Hemostatic Parameters in Healthy Women
Conditions: Hemostasis;   Oral Contraceptive
Interventions: Drug: desogestrel/ethinyl estradiol and ethinyl estradiol;   Drug: desogestrel/ethinyl estradiol
9 Completed Post-marketing, Observational Study to Confirm the Safety and Efficacy of MARVELON (Study P06083)
Condition: Contraception
Intervention: Drug: Ethinylestradiol + Desogestrel
10 Completed Administration of Oral Contraceptives at Different Times of the Follicular Phase of the Menstrual Cycle
Condition: Contraception
Intervention: Drug: 0.15mg desogestrel /0.03mg ethinyl estradiol
11 Completed A Study to Evaluate Ovarian Follicular Activity and Hormone Levels for DR-102 Compared to Two 28-Day Oral Contraceptives
Conditions: Follicle Development;   Ovarian Follicle;   Follicle Count;   Follicle Size;   Oral Contraceptive
Interventions: Drug: Desogestrel/ethinyl estradiol and ethinyl estradiol;   Drug: 28-day drospirenone oral contraceptive;   Drug: 28-day levonorgestrel oral contraceptive
12 Unknown  Continuous Versus Cyclic Use of Oral Contraceptive Pills in Adolescents
Condition: Contraception
Interventions: Drug: Desogestrel-Ethinyl Estradiol 21 tablets;   Drug: Desogestrel-Ethinyl Estradiol 28 tablets
13 Unknown  Therapeutic Effect of Desogestrel on Ventilatory Control in Patients With Congenital Central Hypoventilation Syndrome
Condition: Congenital Central Hypoventilation Syndrome
Intervention: Drug: Desogestrel
14 Completed The Effect of Hormonal Contraceptives on Androgens and Glucose Metabolism
Condition: Contraception
Interventions: Drug: Desogestrel-Ethinyl Estradiol contraceptive pill;   Drug: Etonogestrel-Ethinyl Estradiol vaginal ring;   Drug: Norelgestromin-Ethinyl Estradiol contraceptive patch
15 Recruiting Fat Mediated Modulation of Reproductive and Endocrine Function in Young Athletes
Condition: Exercise-related Amenorrhea
Interventions: Drug: Transdermal 17Beta-estradiol, progesterone;   Drug: Ethinyl Estradiol + Desogestrel;   Dietary Supplement: Sham Comparator
16 Unknown  New Treatments for Troublesome Bleeding in Implanon Users
Condition: Menstrual Problem
Intervention: Drug: Marvelon
17 Recruiting Assessing the Impact of Contraceptives on Bone Health Using 41Ca
Condition: Other Disorders of Bone Development and Growth
Interventions: Drug: Combined Oral Contraceptive (COC);   Drug: Contraceptive Vaginal Ring (CVR)
18 Terminated NuvaRing Versus Marvelon in the Coordination of In Vitro Fertilization Cycles
Condition: Infertility
Interventions: Drug: Contraceptives, Oral;   Drug: Contraceptive, Vaginal ring
19 Completed
Has Results
A Multicenter Study to Evaluate the Effects of a 91-Day Extended Cycle Oral Contraceptive on Hemostatic Parameters in Healthy Women
Conditions: Hemostasis;   Oral Contraceptive
Interventions: Drug: 91-day Levonorgestrel Oral Contraceptive;   Drug: 28-day Levonorgestrel Oral Contraceptive;   Drug: 28-day Desogestrel Oral Contraceptive
20 Completed Safety and Acceptability of Vaginal Rings That Protect Women From Unintended Pregnancy
Condition: Contraception
Interventions: Device: Vaginal Ring - intermittent regimen;   Device: Vaginal Ring - continuous regimen

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.